Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 10598
Gene Symbol: AHSA1
AHSA1
0.020 AlteredExpression disease BEFREE Rituximab inhibits p38 MAPK activity in 2F7 B NHL and decreases IL-10 transcription: pivotal role of p38 MAPK in drug resistance. 15077178 2004
Entrez Id: 57379
Gene Symbol: AICDA
AICDA
0.040 Biomarker disease BEFREE As a B cell genome mutator, activation-induced cytidine deaminase (AID) is a key pathogenic player in both MM and B cell NHL. 31277689 2019
Entrez Id: 57379
Gene Symbol: AICDA
AICDA
0.040 Biomarker disease BEFREE Non-Hodgkin Lymphoma (NHL) is a neoplasm associated with a group of malignancies called AIDs-Defining Malignancies (ADMs) in Human-Immunodeficiency Virus (HIV) -patients. 30555526 2018
Entrez Id: 57379
Gene Symbol: AICDA
AICDA
0.040 Biomarker disease BEFREE Bone marrow trephines (n=130) with infiltration of Hodgkin lymphoma and non-Hodgkin lymphoma of B cell and T-cell type and trephines with reactive lymphoid follicles (n=16) were analyzed immunohistochemically for AID protein. 18776814 2008
Entrez Id: 57379
Gene Symbol: AICDA
AICDA
0.040 AlteredExpression disease BEFREE Additionally, AID expression was seen to differ depending on NHL subtype, with the highest levels of expression seen in those who developed Burkitt's lymphoma. 18090274 2007
Entrez Id: 199
Gene Symbol: AIF1
AIF1
0.010 GeneticVariation disease BEFREE Accordingly, SNPs in RING1/RXRB (rs2855429), AIF1 (rs2857597), and BAT4 (rs3115667) were associated with NHL (P-trends ≤ 0.0002) and both diffuse large B-cell and follicular lymphomas (P-trends < 0.05). 21148756 2011
Entrez Id: 7965
Gene Symbol: AIMP2
AIMP2
0.020 AlteredExpression disease BEFREE Accordingly, we hypothesized that activated p38 MAPK may be associated with the in vivo unresponsiveness to chemotherapy in B-NHL patients. 26475474 2015
Entrez Id: 7965
Gene Symbol: AIMP2
AIMP2
0.020 AlteredExpression disease BEFREE Rituximab inhibits p38 MAPK activity in 2F7 B NHL and decreases IL-10 transcription: pivotal role of p38 MAPK in drug resistance. 15077178 2004
Entrez Id: 10327
Gene Symbol: AKR1A1
AKR1A1
0.010 GeneticVariation disease BEFREE There was a 1.7-fold (95% CI = 1.2-2.4, P = 0.0047) increased risk of NHL for individuals who were variant homozygous for the AKR1A1 (IVS5 + 282T > C) SNP. 17149600 2007
Entrez Id: 1645
Gene Symbol: AKR1C1
AKR1C1
0.010 GeneticVariation disease BEFREE In a population-based case-control study of non-Hodgkin lymphoma (NHL) (n = 518 cases, 597 controls) among women in Connecticut, we analyzed one or more single nucleotide polymorphisms (SNPs) in ten candidate genes (AKR1A1, AKR1C1, AKR1C3, CYBA, GPX1, MPO, NOS2A, NOS3, OGG1, and SOD2) that mediate oxidative stress directly or indirectly in the NADPH oxidase-dependent respiratory burst. 17149600 2007
Entrez Id: 8644
Gene Symbol: AKR1C3
AKR1C3
0.010 GeneticVariation disease BEFREE In a population-based case-control study of non-Hodgkin lymphoma (NHL) (n = 518 cases, 597 controls) among women in Connecticut, we analyzed one or more single nucleotide polymorphisms (SNPs) in ten candidate genes (AKR1A1, AKR1C1, AKR1C3, CYBA, GPX1, MPO, NOS2A, NOS3, OGG1, and SOD2) that mediate oxidative stress directly or indirectly in the NADPH oxidase-dependent respiratory burst. 17149600 2007
Entrez Id: 207
Gene Symbol: AKT1
AKT1
0.040 AlteredExpression disease BEFREE In this study, we found that curcumin inhibits constitutive and radiation-induced expression of the PI3K/AKT pathway and its downstream regulator nuclear factor kappaB (NF-κB) in human Burkitt's lymphoma, a high-grade non-Hodgkin's lymphoma (NHL). 23603894 2013
Entrez Id: 207
Gene Symbol: AKT1
AKT1
0.040 AlteredExpression disease BEFREE Silencing of CKIP-1 promotes tumor proliferation and cell adhesion-mediated drug resistance via regulating AKT activity in non-Hodgkin's lymphoma. 27840970 2017
Entrez Id: 207
Gene Symbol: AKT1
AKT1
0.040 Biomarker disease BEFREE Increased Sam68 expression in NHL resulted in poor prognosis, and it promoted CAM-DR in NHL via AKT. 26478515 2015
Entrez Id: 207
Gene Symbol: AKT1
AKT1
0.040 AlteredExpression disease BEFREE Adhesion to fibronectin (FN) or HS-5 up-regulated DIXDC1 expression, and up-regulation of DIXDC1 resulted in an increased expression of p-AKT, which promoted CAM-DR. Our finding supports the role of DIXDC1 in cell proliferation, cell cycle and CAM-DR in NHLs. 27701018 2016
Entrez Id: 213
Gene Symbol: ALB
ALB
0.010 Biomarker disease BEFREE Advanced stage, low serum albumin and previous ART treatment were the primary prognostic factors associated with poorer outcomes in patients with NHL and HIV infection. 30083224 2018
Entrez Id: 216
Gene Symbol: ALDH1A1
ALDH1A1
0.010 Biomarker disease BEFREE Our data revealed the critical role of ALDH1A1 in NHL and provides a theoretical basis for the use of ALDH1A1 inhibitors in NHL patients. 29399699 2018
Entrez Id: 10840
Gene Symbol: ALDH1L1
ALDH1L1
0.030 GeneticVariation disease BEFREE The GG haplotype for the FTHFD SNPs showed a significant increased risk of NHL (OR 1.40, 95% CI 1.12-1.76, P = 0.002). 25384508 2015
Entrez Id: 10840
Gene Symbol: ALDH1L1
ALDH1L1
0.030 GeneticVariation disease BEFREE A borderline significantly increased risk of NHL was also observed for CBS (rs1801181, Ex13+41C>T), FTHFD (rs2305230, Ex10-40G>T), SHMT1 (rs1979277, Ex12+138C>T), and SHMT1 (rs1979276, Ex12+236T>C), and these associations appeared to be contingent on dietary nutrient intakes. 23913011 2013
Entrez Id: 10840
Gene Symbol: ALDH1L1
ALDH1L1
0.030 GeneticVariation disease BEFREE An elevated risk of NHL was also observed among carriers of the G allele at FTHFD Ex21+31 (all NHL, 1.31, 1.02-1.69; DLBCL, 1.50, 1.05-2.14). 17891500 2007
Entrez Id: 238
Gene Symbol: ALK
ALK
0.100 Biomarker disease BEFREE Anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma (ALCL) is a T cell subtype of non-Hodgkin's lymphoma (NHL). 30588013 2018
Entrez Id: 238
Gene Symbol: ALK
ALK
0.100 Biomarker disease BEFREE Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase (RTK) involved in the genesis of several human cancers; indeed, ALK was initially identified in constitutively activated and oncogenic fusion forms--the most common being nucleophosmin (NPM)-ALK--in a non-Hodgkin's lymphoma (NHL) known as anaplastic large-cell lymphoma (ALCL) and subsequent studies identified ALK fusions in the human sarcomas called inflammatory myofibroblastic tumors (IMTs). 17694547 2008
Entrez Id: 238
Gene Symbol: ALK
ALK
0.100 Biomarker disease BEFREE Our studies demonstrate an alternative mechanism for ALK involvement in the genesis of NHL and suggest that ATIC-ALK activation results from ATIC-mediated homodimerization. 10706887 2000
Entrez Id: 238
Gene Symbol: ALK
ALK
0.100 Biomarker disease BEFREE Anaplastic lymphoma kinase (ALK)-positive non-Hodgkin lymphoma (NHL) was long thought to be a disease occurring uniquely in T or null-cell lymphomas. 21855232 2011
Entrez Id: 238
Gene Symbol: ALK
ALK
0.100 Biomarker disease BEFREE The NPM/ALK-expressing cases were not confined to NHLs with anaplastic morphology and included 15 ALCLs, 6 immunoblastic lymphomas, and 10 diffuse large-cell lymphomas. 7780128 1995